TrialCancer medicine2026

Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study.

Julie Charles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.